SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-039733
Filing Date
2023-05-15
Accepted
2023-05-15 16:01:50
Documents
81
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0323_abvcbio.htm   iXBRL 10-Q 1274735
2 CERTIFICATION f10q0323ex31-1_abvcbio.htm EX-31.1 8004
3 CERTIFICATION f10q0323ex31-2_abvcbio.htm EX-31.2 8129
4 CERTIFICATION f10q0323ex32-1_abvcbio.htm EX-32.1 4107
5 CERTIFICATION f10q0323ex32-2_abvcbio.htm EX-32.2 4091
  Complete submission text file 0001213900-23-039733.txt   7271280

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE abvc-20230331.xsd EX-101.SCH 96219
7 XBRL CALCULATION FILE abvc-20230331_cal.xml EX-101.CAL 37663
8 XBRL DEFINITION FILE abvc-20230331_def.xml EX-101.DEF 328205
9 XBRL LABEL FILE abvc-20230331_lab.xml EX-101.LAB 650859
10 XBRL PRESENTATION FILE abvc-20230331_pre.xml EX-101.PRE 345393
75 EXTRACTED XBRL INSTANCE DOCUMENT f10q0323_abvcbio_htm.xml XML 985976
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40700 | Film No.: 23921801
SIC: 2834 Pharmaceutical Preparations